![]() |
| Natalie Harp appears on FOX Business (Facebook) |
Natalie Harp has stated publicly that Donald Trump saved her life by pushing for a law leading to treatment that helped her overcome a battle with cancer. Experts in science and bioethics, however, say that probably is not how it happened.
A jointly published article by the The UK Telegraph and Yahoo! News, examines a variety of issues Harp's claim raises. Under the headline "Natalie Harp claims Donald Trump saved her life. Really?" Ben Stockton writes:
Donald Trump's devoted aide Natalie Harp has long told the story about how the president – whom she refers to as "my Good Samaritan" – saved her life.
In June 2019, the then-27-year-old was interviewed on Fox & Friends. She spoke gushingly about the president, suggesting the Right To Try Act, which he had signed into law the year before, had given her access to experimental drugs to treat her bone cancer.
"As I like to say, I'm not dying from cancer any more, thanks to President Trump," she said.
The interview caught the eye of Mr Trump: "She lit up the television screen like very few people I've ever seen," he said during a speech in Washington DC a couple of weeks later.
"She talked about how they were preparing her for death. And because of Right To Try, she's now living."
Harp has become an almost constant presence around the president, earning the nickname "the human printer -- and in the past week, turning into a headline-making news figure. Stockton writes:
Ms Harp, now 35, worked on Mr Trump's 2024 presidential campaign. And since he re-entered the White House in 2025, she has become one of the president's closest staffers, known in Washington as a conduit for getting information to him.
But experts have raised doubts about key elements of the story that first brought her into Trump's orbit.
"The details never made a great deal of sense," Jeremy Snyder, a bioethics professor at Simon Fraser University, said.
He has questioned whether Ms Harp accessed the treatment because of Mr Trump's Right To Try Act, as she and the president have claimed.
Ms Harp has previously said a medical error led her to be injected with sterile water, which left her "housebound and searching for care."
"Instead of studying my symptoms to diagnose my condition, my Democrat-controlled state and country offered me opioids, barbiturates, medical marijuana, disability, do-not-resuscitate orders, and yes, Death With Dignity," she wrote in a now-deleted LinkedIn post in 2019.
She developed bone cancer, which she said was not cured by the two chemotherapy treatments available. Doctors apparently told her she would have to wait for other treatments to be approved.
The act became a focal point of Mr Trump's health policy during his first term, and when he signed it into law in May 2018, he said it would give "terminally ill patients the right to try experimental life-saving treatments."
In her LinkedIn post, Harp wrote:
When I failed two available chemotherapies for my rare disease and was denied from clinical trials, my oncologist said I would have to suffer through the symptoms for several more months . . . while awaiting a new round of FDA approvals for the clinical-trial drugs to which I was denied access.
Donald Trump had another option ready: Right to Try. While some may argue this legislation has not benefited the terminally ill or was repetitive to existing law, I beg to differ. My oncologist didn't tell me I had other options; Donald Trump did. So I found another oncologist who was willing to try a different approach -- an FDA-approved immunotherapy drug for an unapproved use. Now my numbers are stabilizing and so is my pain.
From The Telegraph/Yahoo! report:
Ms Harp suggested she was one of those patients who benefited – an experimental treatment she was prescribed apparently worked and her condition improved.
Two days after that 2019 LinkedIn post, she was invited onto Fox & Friends, where she was spotted by Mr Trump. And a couple of weeks later, during a speech at the Faith & Freedom Coalition's Road to Majority annual conference in Washington DC he invited her onstage.
Before the end of the year, according to The Washington Post, she had joined the advisory board of his 2020 campaign.
But Mr Snyder pointed to the fact that Ms Harp had first posted on X (then Twitter) about receiving treatment for her illness in March 2018, two months before Mr Trump signed the Right To Try Act.
She still credited the president with her treatment, who she said was "setting records in speeding up the drug approval process," according to an archived version of the post reviewed by The Telegraph.
"The chemo I'm on now wasn't approved five years ago," she added. She has not disclosed which drug she was treated with.
In her later LinkedIn post and public appearances, she appeared to suggest that Mr Trump's Right To Try Act was responsible.
"You got an experimental treatment because there's Right To Try?" she was asked during an interview with Fox Business. "Yes," she replied.
For Mr. Snyder, it just does not add up, Blockton writes:
But, Mr Snyder said, "the timeline makes no sense as it's prior to any changes that he [Mr Trump] made."
He first wrote about her story's apparent discrepancies in an article for The Washington Post in November 2019.
Snyder is not alone in having doubts, Blockton reports:
A year later, Peter Lurie, a former FDA official, wrote in a blog post that Ms Harp's telling of her story has "dubious encounters with the truth".
He pointed to Ms Harp's claim that, according to her LinkedIn post, she had been treated with "an FDA-approved immunotherapy drug for an unapproved use."
Mr Trump's Right To Try Act, however, sought to open up access to drugs that had not gone through the FDA approval process.
"What she said cannot be true," Mr Lurie, who is now the executive director of the Center for Science in the Public Interest, told The Telegraph.
"It cannot be that -- but for Right To Try -- she would not have had access to this drug. By her own description, if it was approved, she could have had access to the drug, and Right To Try wouldn't have improved her access."
.jpeg)
.jpeg)
.jpeg)